Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms C-11-MK-6884, MK-6884, [11C]MK-6884 |
Target |
Action antagonists |
Mechanism M4 receptor antagonists(Muscarinic acetylcholine receptor M4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H25N5O |
InChIKeyPREPVVXBTJBVOZ-UHFFFAOYSA-N |
CAS Registry2102194-04-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | United States | 17 Apr 2020 |
Phase 1 | 20 | (Part 1, Healthy Participants) | mnozutbemm = qamnfamjov mkuraollys (buhbfxwmcj, wlmqshvbqp - gxircrokyw) View more | - | 28 Feb 2019 | ||
(Part 2, Healthy Elderly Participants) | mnozutbemm = ctnevckjak mkuraollys (buhbfxwmcj, prkwlnclij - fjbojxvcjc) View more |